Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
2348 On Other Exchanges
2348 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tung Ming Li

AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Tung Ming Li has been an Executive Director of Dawnrays Pharmaceutical Holdings Ltd. since January 14, 2004. Mr. Li has over twenty years of experience in the pharmaceutical industry in the PRC, and began his career in product development, promotion, sales and corporate management in the pharmaceutical market in the PRC in 1980. Mr. Li joined Dawnrays Pharmaceutical Holdings Ltd. in April 2000, and is responsible for the development and promotion of the Group's new ...

Read Full Background

Corporate Headquarters*

CNT Tower
Wanchai, -- --

Hong Kong

Phone: --
Fax: --

Board Members Memberships*

Executive Director


There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Total Annual CompensationCNY534,000

Stock Options*

All Other CompensationCNY17,000

Total Compensation*

Total Annual Cash CompensationCNY589,000
Total Short Term CompensationCNY534,000
Other Long Term CompensationCNY17,000
Total Calculated CompensationCNY589,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2348:HK $6.68 HKD -0.01


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at